Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Novartis
Mallinckrodt
Express Scripts
Johnson and Johnson
Merck
Cipla
Medtronic
Citi
Federal Trade Commission

Generated: January 20, 2018

DrugPatentWatch Database Preview

DIURIL Drug Profile

« Back to Dashboard

Which patents cover Diuril, and when can generic versions of Diuril launch?

Diuril is a drug marketed by Oak Pharms Akorn and Salix Pharms and is included in two NDAs.

The generic ingredient in DIURIL is chlorothiazide. There are forty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the chlorothiazide profile page.
Drug patent expirations by year for DIURIL
Pharmacology for DIURIL
Ingredient-typeThiazides
Drug ClassThiazide Diuretic
Physiological EffectIncreased Diuresis
Medical Subject Heading (MeSH) Categories for DIURIL

US Patents and Regulatory Information for DIURIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Oak Pharms Akorn DIURIL chlorothiazide sodium INJECTABLE;INJECTION 011145-005 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Oak Pharms Akorn DIURIL chlorothiazide TABLET;ORAL 011145-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Salix Pharms DIURIL chlorothiazide SUSPENSION;ORAL 011870-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Oak Pharms Akorn DIURIL chlorothiazide TABLET;ORAL 011145-004 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
US Army
Harvard Business School
Daiichi Sankyo
Julphar
QuintilesIMS
Cipla
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot